1.
Adiponectin: mechanistic insights and clinical implications
by Turer, A. T
Diabetologia, 2012-06-12, Vol.55 (9), p.2319-2326

2.
Genome-wide Association Study Identifies Genes for Biomarkers of Cardiovascular Disease: Serum Urate and Dyslipidemia
by Wallace, Chris
American journal of human genetics, 2008, Vol.82 (1), p.139-149

3.
A genome-wide association study of plasma total IgE concentrations in the Framingham Heart Study
by Granada, Mark, MD
Journal of allergy and clinical immunology, 2011, Vol.129 (3), p.840-845.e21

4.
Gene-centric Association Signals for Lipids and Apolipoproteins Identified via the HumanCVD BeadChip
by Talmud, Philippa J
American journal of human genetics, 2009-11-13, Vol.85 (5), p.628-642

5.
Burden of Rare Sarcomere Gene Variants in the Framingham and Jackson Heart Study Cohorts
by Bick, Alexander G
American journal of human genetics, 2012-09-07, Vol.91 (3), p.513-519

6.
Clinical practice The care of children with Down syndrome
by Weijerman, M.E
European journal of pediatrics, 2010, Vol.169 (12), p.1445-1452

7.
Cardiovascular Phenotype in Turner Syndrome—Integrating Cardiology, Genetics, and Endocrinology
by Mortensen, Kristian H
Endocrine reviews, 2012-10, Vol.33 (5), p.677-714

8.
Cardiovascular disease in Noonan syndrome
by Prendiville, Terence W
Archives of disease in childhood, 2014-07, Vol.99 (7), p.629-634

9.
Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)
by Woodward, Mark
Heart (British Cardiac Society), 2007-02, Vol.93 (2), p.172-176

10.
Chemerin, a Novel Adipokine in the Regulation of Angiogenesis
by Bozaoglu, Kiymet
The journal of clinical endocrinology and metabolism, 2010-05, Vol.95 (5), p.2476-2485

11.
The thrifty phenotype hypothesis revisited
by Vaag, A. A
Diabetologia, 2012-05-30, Vol.55 (8), p.2085-2088

12.
Pharmacogenomic Association of Nonsynonymous SNPs in SIGLEC12, A1BG, and the Selectin Region and Cardiovascular Outcomes
by McDonough, Caitrin W
Hypertension (Dallas, Tex. 1979), 2013-07, Vol.62 (1), p.48-54

13.
Atrial Natriuretic Peptide Genetic Variant rs5065 and Risk for Cardiovascular Disease in the General Community: A 9-Year Follow-Up Study
by Cannone, Valentina
Hypertension (Dallas, Tex. 1979), 2013-11, Vol.62 (5), p.860-865

14.
Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide: Biomarkers for Mortality in a Large Community-Based Cohort Free of Heart Failure
by McKie, Paul M
Hypertension (Dallas, Tex. 1979), 2006-05, Vol.47 (5), p.874-880

15.
Population Structure, Admixture, and Aging-Related Phenotypes in African American Adults: The Cardiovascular Health Study
by Reiner, Alexander P
American journal of human genetics, 2005, Vol.76 (3), p.463-477

16.
Genetic loci associated with lipid concentrations and cardiovascular risk factors in the Korean population
by Park, Mi-Hyun
Journal of medical genetics, 2011-01, Vol.48 (1), p.10-15

17.
MicroRNAs Are Involved in End-Organ Damage During Hypertension
by Heggermont, Ward A
Hypertension (Dallas, Tex. 1979), 2012-11, Vol.60 (5), p.1088-1093

18.
Family-Based Association Studies for Next-Generation Sequencing
by Zhu, Yun
American journal of human genetics, 2012-06-08, Vol.90 (6), p.1028-1045

19.
Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coro...
by Lio, D
Journal of medical genetics, 2004-10, Vol.41 (10), p.790-794

20.
Hepatic Lipase, Genetically Elevated High-Density Lipoprotein, and Risk of Ischemic Cardiovascular Disease
by Johannsen, Trine Holm
The journal of clinical endocrinology and metabolism, 2009-04, Vol.94 (4), p.1264-1273
